Despite the presence in our case of a somatic TP53 mutation, that in pediatric brain tumors is restricted to HGG and is independently associated with an adverse outcome [21], the patient underwent RT, considering the unavailability of other viable therapeutic alternatives. The gene discussed is TP53; the disease is brain neoplasm.